Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.26
-0.09 (-1.68%)
At close: May 13, 2025, 4:00 PM
5.11
-0.15 (-2.85%)
Pre-market: May 14, 2025, 8:34 AM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $264.41 million as of May 14, 2025. Its market cap has decreased by -24.60% in one year.
Market Cap
264.41M
Enterprise Value
132.09M
1-Year Change
-24.60%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $264.41M, a decrease of -33.52%. That is a compound annual growth rate of -10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 268.94M | -34.50% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |